What is the impact of collective purchasing on pharmaceutical companies?
There were many impacts on pharmaceutical companies: ** I. Short term impact ** 1. ** In terms of performance ** - Regardless of whether they won the bid or not, the operating income and profits of pharmaceutical companies would be greatly affected in the short term. The market often looked down on the short-term development prospects of pharmaceutical companies. And as the scope of the collection continued to expand, almost all pharmaceutical companies in the industry would be affected. 2. ** In terms of product sales ** - For pharmaceutical companies that did not have new products on the market, if the existing products were purchased, they might face revenue pressure. For example, Tonghua Dongbao's short-term performance had been affected by the purchase. However, for pharmaceutical companies that have recently launched heavyweight products, such as the empyrean tablets, liirked injection, and endon 30/50 pre-mixed hormone that have been launched by Tonghua Dongbao in the past two years, the collective purchase may promote the sales volume of these products. ** 2. Long-term impact ** 1. ** Enterprise management and quality standards ** - Pharmaceutical companies that participated in the evaluation of the collective purchase needed to have certain qualifications and meet the national pharmaceutical production quality standards. This would encourage pharmaceutical companies to continuously improve their management level. Otherwise, they would be suspended from participating in the application of the collective purchase. 2. ** Market position and sales model ** - Pharmaceutical companies that won the bid could exchange for a larger market share at a low price, reduce intermediate sales links, reduce sales expenses, and obtain a leading position in the market. In the long run, it would help reduce the impact on operating income and profits, and help establish a benchmark position in the pharmaceutical industry. 3. ** Enterprise transformation and innovation ** - The gathering forced pharmaceutical companies to transform and upgrade, prompting them to increase their innovation efforts, allowing a large amount of capital to flow into the field of pharmaceutical innovation, increasing investment in scientific research and innovation to improve the core advantages of pharmaceutical companies. In the field of innovation, pharmaceutical companies had the initiative to participate in collective purchasing, and their bargaining power was also strong, which was beneficial to the long-term development of pharmaceutical companies and the entire industry. 4. ** Impact on different types of pharmaceutical companies ** - The earliest and largest affected by the collective purchase were the mature generics companies in China. In the early days, such companies relied on the production of patent formulas that had passed the protection period. The production cost was low and the price was high. There were many intermediate links. They were mature but lacked innovation ability, the product update and repetition were slow, and they could not keep up with the international advanced level. The supply of core raw materials was insufficient. They lacked the right to speak and price in the process of collective purchase. The profit margin was severely compressed, the long-term development momentum weakened, and the market share gradually decreased. However, this would also force them to transform and improve their independent research and development capabilities. In addition, in the upcoming tenth batch of collective purchases, although it was the largest and most competitive collective purchase in history, for the pharmaceutical companies participating in it, the collective purchase always had the attribute of exchanging price for quantity. The profit margin of the enterprise had a certain contraction. The domestic pharmaceutical companies had entered the transformation cycle and needed to build a new growth logic. For example, some pharmaceutical companies could find new growth paths by speeding up the sea or making good products. Read more exciting novels for free
What are the pharmaceutical positions in pharmaceutical companies?
Pharmaceutical companies had positions in pharmaceutical research and development, clinical, production quality management, and other positions. They would also recruit pharmaceutical graduates to engage in pharmaceutical preparations, drug management, pharmacists, and other positions. They also included pharmaceutical representatives, registered pharmacists, pharmacy salespersons, medical information communication specialists, and other positions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the types and responsibilities of pharmaceutical companies?
There were many jobs in pharmaceutical companies. The following were the common jobs and their responsibilities: ** 1. Quality Control Inspector (Physical and chemical analysis)** 1. ** Safety Operation ** - According to the equipment usage SOPs and product inspection SOPs, wear safety protection equipment, and follow various safety management systems to ensure personal and laboratory environment safety. 2. ** Inspection Operation ** - Strictly follow the operating procedures related to the inspection operation, and skillfully use various instruments such as moisture, potential, Toc, conductivity, UV-A, I-R, liquid phase, Toc, and gas phase. 3. ** Instrument maintenance ** - Maintain all kinds of inspection instruments and equipment according to the requirements to keep them in good condition. 4. ** In terms of product testing ** - To participate in the product stability investigation and provide data, be responsible for the verification and confirmation of analytical methods during the product transfer process, carry out the testing of raw materials and auxiliary materials and products, and be responsible for the testing of purified water. 5. ** Abnormality handling ** - Report the abnormal results during the inspection process and participate in the investigation. Complete other tasks assigned by the superior. ** 2. Pharmaceutical Enterprise Customer Manager ** - He was mainly responsible for customer management related to pharmaceutical companies, but the specific responsibilities were not mentioned in detail. From the job title, it was speculated that he needed to develop and maintain the customer resources of pharmaceutical companies, understand customer needs, and promote pharmaceutical products or services. ** 3. CT A (clinical research assistant)** 1. ** In terms of document management ** - The job mainly involved meeting records, document management, and other civilian work. 2. ** In terms of affairs coordination ** - He was responsible for contract payment, stamping, and other matters. Compared to the CPR, he did not need to deal with hospitals, doctors, and subjects frequently, and the work pressure was relatively small. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the good positions in pharmaceutical companies?
There were many positions in pharmaceutical companies that had their own advantages: ** 1. Quality Control (QC-related positions ** 1. ** Physical-chemical analysis, QC-inspector ** - It was a good choice for those who had a bachelor's degree or above in pharmacy, analytical chemistry, microbiology, and other related majors. Those who had the professional knowledge of the pharmaceutical company's chemical and physical analysis inspector position were more favored. - The work content included following the standard operating procedures for the use of instruments and product inspection to ensure safety; skillfully and correctly using a variety of instruments (such as moisture, potential, Toc and other related instruments); maintaining the inspection instruments and equipment; participating in product stability inspections; and being responsible for raw materials and product testing. - In terms of salary and benefits, for example, in Puli Pharmaceuticals, the salary was 7 - 10K. There were eight hours of two-day rest, five insurances and one fund, free meals in the canteen, free two-person apartments, holiday benefits, team-building activities, communication subsidies, high-temperature subsidies, birthday gifts, free physical examinations, and so on. ** 2. Clinical-related positions (such as CTAs)** 1. ** CT A (clinical research assistant)** - It was suitable for people who changed careers from nurses. - There are obvious advantages in work, such as "freedom of vacation", normal rest during holidays; flexible work schedule, 9 - 5, 5 - 5, 2 - 2 without punching cards; regular work schedule; more time to spend with family and children; more career possibilities, with experience accumulation, you can transfer to positions such as CARA, PM, MV, QL, IP, etc.(However, except for the undergraduate degree of CARA and IP, most of the others require a master's degree or above.) The work content is relatively simple, mainly involving meeting minutes, document management, contract payment, stamping, and other civilian work. The pressure is relatively small. ** 3. Marketing related positions ** 1. ** Position of product manager ** - It involved the work of product specialists, academic promotion, marketing specialists, medical managers, etc., such as product specialists responsible for academic promotion. - His job responsibilities included managing the products and other related matters, and his career development path was rich. 2. ** Medical Contact Officer (MTL) Position ** - They had to have specific skills that were different from medical advisors and have their own career development path. ** IV. Fermenting workshop director position (for those with some work experience and college education)** - For people with 5 - 10 years of work experience and a college degree, the position of the director of the fermentation workshop was an option. The annual salary was 12k-17k, and he was responsible for the management of the fermentation workshop in pharmaceutical companies with a scale of 100 - 499 people. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the job requirements for pharmaceutical companies?
Different pharmaceutical companies have different job requirements. The following are some common job requirements: - ** CT A Position **: This is a basic position. Although there is no mention of academic qualifications, there is a chance to transfer to other positions as you accumulate experience. The work mainly involved meeting records, document management, contract payment, stamping, and other civilian work. - ** Director of the fermentation workshop (pharmaceutical company)**: Requires a college degree, major in pharmacy, biology, chemistry, medicine, food, and other related majors. Intermediate or above titles are preferred. More than 6 years of working experience in the pharmaceutical industry, with production knowledge related to fermentation and more than 3 years of production management experience in the fermentation workshop of a pharmaceutical company. Familiar with the laws, regulations, safety knowledge, and familiar with the production process and various management systems and operating specifications. Having practical experience in pharmaceutical production management and the ability to solve practical problems; Strong adaptability, able to withstand greater work pressure, self-adjustment and response ability; Awareness of confidentiality, quality awareness, good professional ethics and professional ethics, correct working attitude, proactive, strong sense of responsibility, honesty and trustworthiness, initiative, professionalism, and teamwork spirit. - ** QCPosition **: Most pharmaceutical companies require at least a bachelor's degree. - ** Position in supply chain QAs **: Requirement: Pharmacy related major, bachelor's degree or above, at least 2 years of supply chain QAs working experience in pharmaceutical manufacturing companies, familiar with relevant regulations of the GMP system, and can use PS and ADC software is preferred. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The instruments that the quality inspectors of pharmaceutical companies need to use are
The quality inspectors of pharmaceutical companies needed to use high-performance liquid chromatography, gas chromatography, ultraviolet-visible spectrums, infrared spectrums, atomic absorption spectrums, and other precision instruments. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the training contents of the person in charge of pharmaceutical companies?
The training content for the person-in-charge of pharmaceutical companies usually included the following aspects: 1. ** Drug market analysis **: Understand the current situation and development trend of the drug market, analyze the advantages and disadvantages of competitors, and master the basic concepts and methods of marketing. 2. ** Drug Quality Management **: How to establish and improve a drug quality management system, covering key links such as drug testing, quality control, and compliance review. 3. ** Drug Purchasing Management **: Learn the basic principles and procedures of drug purchasing, understand the signing and execution of purchase contracts, and master supplier management and negotiation skills. 4. ** Drug inventory and logistics management **: Master the methods and skills of inventory management, understand the process and requirements of drug logistics, and learn the measures to improve logistics efficiency. 5. ** Drug sales management **: establish a sales team and develop sales plans, learn marketing strategies and sales skills, master sales data analysis and customer relationship management. 6. ** Drug regulations and compliance requirements **: Understand the requirements of relevant regulations and policies for pharmaceutical companies, learn how to establish a compliance management system and improve internal control mechanisms. 7. ** Drug Safety Management **: Learn the basic knowledge and requirements of drug safety, understand the procedures for handling adverse drug reactions and drug recall, and master the emergency measures for drug safety incidents. 8. ** Enterprise Management and leadership **: Knowledge related to effective management and leadership of enterprises. In addition, for the person in charge of the pharmaceutical production company, it also involved knowledge about the organization, such as identifying the various departments.(production, quality, material storage, equipment, sales, personnel management, etc.), understand different organizational structure models (three-level management system, straight-line system, functional system, division system, etc.) and their application, as well as the responsibilities of key positions (such as sales director, human resources manager, etc.), so as to ensure that the entire process of drug production is under control and ensure the quality of drugs. At the same time, the training also focused on improving the quality of the staff and the cultivation of professional ethics. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Impact of the epidemic on animation companies
Taking the Japanese animation companies during the epidemic in 2020 as an example, the epidemic had the following impacts on them: - ** Comics market **: - Affected by the development of the Internet, the Japanese paper comics publishing market was already relatively depressed, and the development of electronic comics was difficult to make up for. The market size had continued to decline since 2014. However, in 2020, the popularity of the popular comic book "Ghost Destroyer Blade" and the Japanese government's implementation of quarantine measures in many places affected by the epidemic pushed up the sales of comics, bringing the Japanese comics market to 612.6 billion yen, the highest since 1978, up 23% from the previous year. - ** In the animation market **: - The production of television animation and theater animation both declined. In 2020, a total of 278 TV animations were produced in Japan, with a year-on-year decrease of 7.95% and a year-on-year decrease of 5.72% in production time. The decline in the number of theater animations and the market was even more obvious. In 2020, a total of 66 theater animations were produced, with a year-on-year decrease of 27.47% and a production time of 4873 minutes, with a year-on-year decrease of 34.06%. The scale of the Japanese theater animation market has generally been on the rise since 2000, but in 2020, due to the epidemic, cinemas around the world were closed on a large scale, which dealt a huge blow to the industry. In 2020, the overall market size of the Japanese animation industry reached 242.61 billion yen, down 3.52% year-on-year, the first decline since 2014. - ** Voice actor and actor **: - According to Japan's NKO, most of the offline activities such as performances and meet-and-greet meetings were suspended due to the COvid-19 epidemic, and many actors and voice actors were in financial crisis. 52.3% of the voice actors and actresses said that they lacked a source of income and needed to consume their savings, while 26.3% said that their savings could no longer cover their living expenses and needed to borrow money to survive. Moreover, many popular and classic dramas had been delayed. The workload of the voice actors had decreased, and their lives had become more difficult. However, from the perspective of the overall animation industry, the market size of the Japanese animation industry reached 303.87 billion yen in 2020, an increase of 0.87% year-on-year. Although the growth rate was small, it could still maintain growth under the overall environment of the entertainment industry affected by the epidemic, which showed that it had a high ability to resist risks. At the same time, GuoChuang Animation maintained a good momentum of development in April 2020. For example, 2D animation "Under One Man 3" and 3D animation "Douluo Continent" maintained a normal frequency of updates. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Was the storyline in I'm Not the Drug God caused by the monopoly of domestic pharmaceutical companies?
The storyline in I'm Not the Drug God was not completely monopolized by domestic pharmaceutical companies. The protagonist of the movie, Cheng Yong, was the boss of a pharmaceutical agency. He maintained the company's survival by selling pirated drugs. However, due to the existence of drug pirates, patients could not obtain genuine drugs from legal channels, resulting in the price of genuine drugs being too high for many patients to afford. Under such circumstances, Cheng Yong decided to help patients buy pirated drugs and use the profits he earned to help more patients. However, his actions were opposed by the boss of the pharmaceutical company, so the two of them started a fierce battle. Therefore, the plot of the movie was not entirely caused by the monopoly of domestic pharmaceutical companies. Instead, it involved the problem of drug pirates and the high price of legitimate drugs, as well as the struggle between the bosses of pharmaceutical companies.
What are the key elements in collective impact success stories?
One key element is a common agenda. All the parties involved need to agree on the overall goal, like in the case of improving a neighborhood's safety. Everyone from the local police, community groups, and residents should be on the same page regarding what safety means and how to achieve it. Another element is shared measurement. They need to have a way to measure progress, for example, the number of crimes reported in the neighborhood as an indicator of safety. Also, mutually reinforcing activities are important. If the police are increasing patrols and the community is organizing neighborhood watch programs, these activities support each other towards the common goal of safety.
How do the pharmaceutical industry top stories impact the public?
The top stories in the pharmaceutical industry can have a direct impact on the public. For example, if there is a new drug approval, it might mean better treatment options for patients. If it's a story about a drug recall, it can raise concerns among the public about the safety of medications they are taking. Also, stories about drug pricing can influence public perception of the industry and may lead to calls for more affordable drugs.